ghk-cu powder Copper Peptide (100MG) GHK-Cu Copper Peptide Powder –

has acted as a consultant for, received grant or research support from, is a shareholder in, and a holds a patent from Centocor JNJ

Recently, phase III clinical trials for obesity with efpeglenatide are ongoing

Key publications: 'Tripeptide in human serum which prolongs survival of normal liver cells' (1973), 'Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells' (1980, Nature), 'The human tri-peptide GHK and tissue remodeling' (2008), 'GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration' (2015), 'Regenerative and Protective Actions of the GHK-Cu Peptide' (2018)

Due to its experimental status, it is typically considered only under medical supervision within functional or regenerative care programs